Studies have shown increased levels of proinflammatory factors such as TNF-α, IL-6, circulating lipopolysaccharide, antimyogenic mediators, and promyogenic mediators (myostatin and insulin-like growth factor-1) in IBD patients [75, 76]. The gene discussed is TNF; the disease is inflammatory bowel disease.